Factors associated with pneumococcal and influenza vaccination in hospitalized people aged ≥65 years

Epidemiology and Infection

Volumn 139, Issue 5, 2011, Pages 666-673

  Sintes, X ^a,b,c   Nebot, M ^a,b,d   Izquierdo, C ^c   Ruiz, L ^c   Dominguez A ^b,e   Bayas, J M ^f   Vera, I ^f   Carratala J ^e,g   Sousa, D ^h  

^a AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c Barcelona Health Region ^*  (Spain)

^d UNIVERSITAT POMPEU FABRA   (Spain)

^e UNIVERSITY OF BARCELONA   (Spain)

^f INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^g HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^h HOSPITAL JUAN CANALEJO   (Spain)

Author keywords

Elderly people; influenza vaccine; pneumococcal vaccine; vaccination factors

Indexed keywords

INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EDUCATIONAL STATUS; ELDERLY CARE; FEMALE; HOSPITAL PATIENT; HUMAN; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; INTERMETHOD COMPARISON; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PNEUMONIA; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SOCIAL CLASS; SOCIOECONOMICS; SPAIN; UTILIZATION REVIEW; VACCINATION;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INFLUENZA VACCINES; MALE; PNEUMOCOCCAL VACCINES; SPAIN; VACCINATION;

EID: 79957739897     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268810001846     Document Type: Article

References (29)

1. Centers for Disease Control and Prevention. Prevention of pneumococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report 1997; 46: 1-24.
2. Salleras L, et al. 23-valent pneumococcal vaccine [in Spanish]. In: Salleras L, ed. Vacunaciones preventivas, 2nd edn. Barcelona: Masson, 2003, pp. 363-398.
3. Hedlund J, et al. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccine in elderly people: a 1 year follow-up. Vaccine 2003; 21: 3906-3911. (Pubitemid 37345133)
4. Butler JC, et al. Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. Journal of the American Medical Association 1993; 270: 1826-1831. (Pubitemid 23301436)
5. Domínguez A, et al. Effectiveness of pneumococcal vaccination for elderly people in Catalonia (Spain): a case-control study. Clinical Infectious Diseases 2005; 40: 1250-1257. (Pubitemid 40570233)
6. Jackson LA, Neuzil KM. Pneumococcal vaccine. In: Plotkin S, Orenstein W, Offit P, eds. Vaccines, 5th edn. Philadelphia : Saunders Elsevier, 2007, pp. 569-604.
7. Batalla J, et al. Pneumococcal vaccination coverage among people aged o65 years in Catalonia [in Spanish]. In: Campins M, Moraga F, eds. Vacunas. Barcelona: Prous Science, 2002, pp. 173-180.
8. Vila Córcoles A, et al. Coverage and association with clinical variables of antipneumococcal vaccination of the population over 65 years old in Tarragona- Valls. Revista Española de Salud Publica 2005; 79: 645-654. (Pubitemid 44112806)
9. Vila-Córcoles A, et al. Evolution of vaccination rates after the implementation of a free systematic pneumococcal vaccination in Catalonian older adults: 4-years follow-up. BMC Public Health 2006, 6: 231.
10. Ministerio de Sanidad y Consumo. Salud Pública. Promoción de la Salud y Epidemiología. Vacunación en adultos. Recomendaciones. Año 2004. (http://www.msc.es/en/ciudadanos/ proteccionSalud/vacunaciones/docs/recoVacunasAdultos.pdf). Accessed 21 April 2010.
11. Batalla J, et al. Influenza vaccination coverage in Catalonia [in Spanish]. Vacunas 2001; 2: 130-134.
12. Mayo Montero E, et al. Evolution of the degrees of influenza vaccine (flu shot) coverage in Spain throughout the 1993-2001 period. Analysis by Autonomous Communities. Revista Española de Salud Pública 2004, 78: 481-492. (Pubitemid 39006387)
13. Vazquez-Fernández del Pozo S, et al. Changes in influenza vaccination coverage in Spain from 2001 to 2003. Analysis by autonomous communities. Gaceta Sanitaria 2007; 21: 10-17.
14. Centers for Disease Control and Prevention. Influenza and pneumococcal vaccination levels among persons aged o65 years - United States, 2001. Morbidity and Mortality Weekly Report 2002; 51: 1019-1024.
15. Centers for Disease Control and Prevention. Influenza and pneumococcal vaccination coverage levels among persons aged greater than or equal to 65 years - United States, 1973-1993. Morbidity and Mortality Weekly Report 1995; 44: 506-507, 513-515.
16. Kamal KM, Madhavan SS, Amonkar MM. Determinants of adult influenza and pneumonia immunization rates. Journal of the American Pharmaceutical Association 2003; 43: 403-411.
17. Opstelten W, et al. Introducing a pneumococcal vaccine to an existing influenza immunization program: vaccination rates and predictors of noncompliance. American Journal of Medicine 2001; 111: 474-479. (Pubitemid 33016420)
18. de Andres AL, et al. Influenza vaccination among the elderly Spanish population: trend from 1993 to 2003 and vaccination-related factors. European Journal of Public Health 2007;17: 272-277. (Pubitemid 47356293)
19. Centers for Disease Control and Prevention. Public health and aging: influenza vaccination coverage among adults aged o50 years and pneumococcal vaccination coverage among adults aged o65 years - United States, 2002. Morbidity and Mortality Weekly Report 2003; 52: 987-992.
20. Jiménez-García R, et al. Compliance with influenza and pneumococcal vaccination among patients with chronic obstructive pulmonary disease consulting their medical practitioners in Catalonia, Spain. Journal of Infection 2007; 54: 65-74. (Pubitemid 44932937)
21. Domínguez A, et al. Effectiveness of the Pneumococcal Polysaccharide Vaccine in Preventing Pneumonia in the Elderly. European Respiratory Journal. Published online : 14 January 2010. doi:10.1183/09031936. 00171309.
22. Domingo-Salvany A, et al. Proposal for a social class measure. Working Group of the Spanish Society of Epidemiology and the Spanish Society of Family and Community Medicine. Atención Primaria 2000; 25: 350-363.
23. Kissling E, et al. 'I-Move' towards monitoring seasonal and pandemic influenza vaccine effectiveness : lessons learnt from a pilot multi-centric case-control study in Europe, 2008-9. Eurosurveillance 2009; 14: pii=19388.
24. Dijkstra F, et al. Long time trends in influenza-like illness and associated determinants in The Netherlands. Epidemiology and Infection 2009, 137: 473-479.
25. Christenson B, Lundbergh P. Comparison between cohorts vaccinated and unvaccinated against influenza and pneumococcal infection. Epidemiology and Infection 2002; 129: 515-524. (Pubitemid 36157675)
26. Kyaw MH, et al. Influenza and pneumococcal vaccine distribution and use in primary care and hospital settings in Scotland: coverage, practice and policies. Epidemiology and Infection 2002; 128: 445-455. (Pubitemid 34716373)
27. Sarria A, Timoner A. Determinants of influenza vaccination in persons 65 years of age and older. Revista Española de Salud Pública 2002; 76: 17-26. (Pubitemid 34168727)
28. Bayas JM, Campins M. Vaccinations for immunocompetent adults with chronic diseases : cardiovascular diseases, chronic obstructive pulmonary disease, diabetes mellitus and hepatopathy [in Spanish]. Vacunas 2006; 7 (Suppl. 1) : 80-85.
29. Schoefer Y, et al. Determinants of influenza and pneumococcal vaccination in patients with chronic lung diseases. Journal of Infection 2007; 55: 347-352. (Pubitemid 47381220)